Stay updated on Ledipasvir/Sofosbuvir 12-Week Combo in Genotype 2 HCV Clinical Trial
Sign up to get notified when there's something new on the Ledipasvir/Sofosbuvir 12-Week Combo in Genotype 2 HCV Clinical Trial page.

Latest updates to the Ledipasvir/Sofosbuvir 12-Week Combo in Genotype 2 HCV Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe study record for the ledipasvir/sofosbuvir trial is displayed with its design, participant criteria, treatment arms, outcome measures, results-related dates, and supporting documents.SummaryDifference65%

- Check19 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0 while the page continued to show a 403 Forbidden error.SummaryDifference0.2%

- Check26 days agoChange DetectedA site-wide notice announces changes to NIH terminology and links to transition updates and FAQs.SummaryDifference1%

- Check33 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.1 to v3.7.2; the page remains a 403 Forbidden error.SummaryDifference0.2%

- Check40 days agoChange DetectedThe ClinicalTrials.gov footer revision label changes from v3.7.0 to v3.7.1, while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check54 days agoChange DetectedThe page shows a 403 Forbidden error, indicating restricted access to the study record.SummaryDifference0.2%

Stay in the know with updates to Ledipasvir/Sofosbuvir 12-Week Combo in Genotype 2 HCV Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ledipasvir/Sofosbuvir 12-Week Combo in Genotype 2 HCV Clinical Trial page.